The next board meeting for Whitehawk Therapeutics Inc is on 19 Mar 2026 for the purpose of Aadi Bioscience Inc Fourth Quarter Earnings Results for 2025See details
Whitehawk Therapeutics Inc has a share price target of US$ 5, revenue growth forecast of 4.4%, and profit growth estimate of 76.2% for FY25, based on top 5 analyst calls.